Entrada Therapeutics, Inc. SEC filings TRDA

Entrada Therapeutics, Inc. has 474 filings in SEC EDGAR's recent list, going back to Nov 10, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Entrada Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 10, 2026 —
4 Insider transaction Sep 9, 2026 Sep 4, 2026
4 Insider transaction Sep 9, 2026 Sep 4, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
4 Insider transaction Aug 31, 2026 Aug 27, 2026
4 Insider transaction Aug 31, 2026 Aug 27, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
144/A Filing Aug 10, 2026 —
4 Insider transaction Aug 3, 2026 Jul 30, 2026
4 Insider transaction Aug 3, 2026 Jul 30, 2026
144 Notice of proposed sale Jul 30, 2026 —
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction May 21, 2026 May 20, 2026
4 Insider transaction May 4, 2026 May 4, 2026
4 Insider transaction May 4, 2026 May 4, 2026
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
4 Insider transaction Apr 2, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
144 Notice of proposed sale Mar 9, 2026 —
144 Notice of proposed sale Mar 9, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 4, 2026 —
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
SCHEDULE 13G Ownership over 5% (passive) Nov 25, 2025 —
4 Insider transaction Nov 24, 2025 Nov 21, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 21, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 18, 2025 —
4 Insider transaction Nov 18, 2025 Nov 14, 2025
4 Insider transaction Nov 18, 2025 Nov 14, 2025
144 Notice of proposed sale Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 12, 2025 Nov 10, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Jul 11, 2025 Jul 9, 2025
4 Insider transaction Jul 11, 2025 Jul 9, 2025
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
144 Notice of proposed sale Jul 1, 2025 —
144 Notice of proposed sale Jul 1, 2025 —
144 Notice of proposed sale Jun 30, 2025 —
144 Notice of proposed sale Jun 30, 2025 —
144 Notice of proposed sale Jun 27, 2025 —
144 Notice of proposed sale Jun 27, 2025 —
4/A Form 4/a Jun 18, 2025 May 13, 2024
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
3 Initial insider ownership Jun 3, 2025 Jun 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
4 Insider transaction Apr 4, 2025 Apr 3, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
144 Notice of proposed sale Mar 17, 2025 —
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 4, 2025 —
4 Insider transaction Dec 12, 2024 Dec 10, 2024
4 Insider transaction Dec 12, 2024 Dec 10, 2024
4 Insider transaction Dec 3, 2024 Nov 29, 2024
4 Insider transaction Dec 3, 2024 Nov 29, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
144 Notice of proposed sale Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
4 Insider transaction Nov 6, 2024 Nov 4, 2024
4 Insider transaction Oct 18, 2024 Oct 16, 2024
144 Notice of proposed sale Oct 16, 2024 —
4 Insider transaction Sep 30, 2024 Sep 26, 2024
4 Insider transaction Sep 10, 2024 Sep 9, 2024
4 Insider transaction Sep 10, 2024 Sep 6, 2024
4 Insider transaction Sep 10, 2024 Sep 6, 2024
144 Notice of proposed sale Sep 9, 2024 —
144 Notice of proposed sale Sep 6, 2024 —
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
4 Insider transaction Aug 20, 2024 Aug 16, 2024
144 Notice of proposed sale Aug 16, 2024 —
4 Insider transaction Jul 16, 2024 Jul 12, 2024
4 Insider transaction Jul 16, 2024 Jul 12, 2024
144 Notice of proposed sale Jul 15, 2024 —
144 Notice of proposed sale Jul 12, 2024 —
4 Insider transaction Jul 10, 2024 Jul 8, 2024
144 Notice of proposed sale Jul 8, 2024 —
SC 13D/A Amended ownership over 5% (active) Jun 26, 2024 —
4 Insider transaction Jun 26, 2024 Jun 25, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
144 Notice of proposed sale Jun 13, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction May 20, 2024 May 16, 2024
4 Insider transaction May 20, 2024 May 16, 2024
4 Insider transaction May 16, 2024 May 14, 2024
144 Notice of proposed sale May 16, 2024 —
144 Notice of proposed sale May 16, 2024 —
4 Insider transaction May 10, 2024 May 8, 2024
144 Notice of proposed sale Apr 30, 2024 —
144 Notice of proposed sale Apr 29, 2024 —
144 Notice of proposed sale Apr 26, 2024 —
144 Notice of proposed sale Apr 25, 2024 —
144 Notice of proposed sale Apr 24, 2024 —
144 Notice of proposed sale Apr 23, 2024 —
144 Notice of proposed sale Apr 19, 2024 —
144 Notice of proposed sale Apr 18, 2024 —
144 Notice of proposed sale Apr 17, 2024 —
144 Notice of proposed sale Apr 16, 2024 —
144 Notice of proposed sale Apr 15, 2024 —
144 Notice of proposed sale Apr 12, 2024 —
144 Notice of proposed sale Apr 11, 2024 —
4 Insider transaction Apr 10, 2024 Apr 8, 2024
144 Notice of proposed sale Apr 10, 2024 —
144 Notice of proposed sale Apr 9, 2024 —
144 Notice of proposed sale Apr 8, 2024 —
144 Notice of proposed sale Apr 5, 2024 —
4 Insider transaction Apr 1, 2024 Mar 28, 2024
4 Insider transaction Mar 26, 2024 Mar 22, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
144 Notice of proposed sale Mar 6, 2024 —
144 Notice of proposed sale Mar 6, 2024 —
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
144 Notice of proposed sale Feb 15, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Jan 18, 2024 Jan 16, 2024
4 Insider transaction Dec 26, 2023 Dec 21, 2023
4 Insider transaction Dec 22, 2023 Dec 20, 2023
144 Notice of proposed sale Dec 21, 2023 —
144 Notice of proposed sale Dec 20, 2023 —
144 Notice of proposed sale Dec 19, 2023 —
144 Notice of proposed sale Dec 15, 2023 —
144 Notice of proposed sale Dec 14, 2023 —
144 Notice of proposed sale Dec 13, 2023 —
4 Insider transaction Nov 13, 2023 Nov 13, 2023
144 Notice of proposed sale Nov 13, 2023 —
4 Insider transaction Oct 19, 2023 Oct 17, 2023
4 Insider transaction Sep 15, 2023 Sep 13, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
4 Insider transaction Sep 6, 2023 Sep 1, 2023
144 Notice of proposed sale Sep 6, 2023 —
144 Notice of proposed sale Sep 6, 2023 —
144 Notice of proposed sale Sep 6, 2023 —
4 Insider transaction Sep 5, 2023 Sep 1, 2023
3 Initial insider ownership Sep 5, 2023 Sep 1, 2023
4 Insider transaction Aug 16, 2023 Aug 14, 2023
144 Notice of proposed sale Aug 14, 2023 —
4 Insider transaction Aug 4, 2023 Aug 2, 2023
144 Notice of proposed sale Aug 2, 2023 —
4 Insider transaction Jul 12, 2023 Jul 10, 2023
4 Insider transaction Jul 12, 2023 Jul 10, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TRDA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
, Emerging growth company
SEC CIK
1689375
Former names
CycloPorters, Inc. (until Nov 10, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.